⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 19, 2024Arthritis & Rheumatology

Performance of the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome in a Mexican cohort

Erik Cimé‐Aké Gabriela Hernández‐Molina Amaya Llorente‐Chávez Eduardo Martín‐Nares

View at Publisher

Ask AI

Bookmark

Share

Abstract

The objective is to assess the performance of the 2023 American College of Rheumatology/EULAR classification criteria (2023 AECC) for antiphospholipid syndrome (APS) in a Mexican cohort.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cimé‐Aké et al. (2024) studied this question.

synapsesocial.com/papers/68e5fb74b6db64358758f44b https://doi.org/10.1002/art.42957

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Performance validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort2024 · 24 citations
2The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey2024 · 5 citations
3Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice2024 · 7 citations
4OP0258 PERFORMANCE VALIDATION OF THE 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA IN AN ANTIPHOSPHOLIPID SYNDROME COHORT2024
5Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria2024 · 10 citations

More related papers

Development of the 2023 <scp>ACR/EULAR</scp> Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision Analysis2024
Assessing the sensitivity and the clinical impact of the 2023 <scp>ACR</scp> / <scp>EULAR</scp> classification criteria in Obstetric Antiphospholid Syndrome: findings from a multicenter Italian cohort with a long‐term follow‐up2026
AB0007 COMPARATIVE ANALYSIS OF THE SYDNEY (2004) AND ACR/EULAR (2023) CLASSIFICATION CRITERIA FOR ANTIPHOSPHOLIPID SYNDROME: EMPHASIS ON RECENTLY INCLUDED CLINICAL MANIFESTATIONS AS PART OF THE ACR/EULAR CRITERIA2024

More from Arthritis & Rheumatology

Single‐cell analysis reveals CXCL16 + dendritic cells and clonally expanded GZMK + CD4 T cells driving joint inflammation in psoriatic arthritisTue,
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Placebo‐Controlled APEX StudyTue,